Solid Biosciences Inc. (NASDAQ: SLDB) is a Healthcare company (Biotechnology) with a market capitalization of $695M. The Maz Rating grades it against the other companies in its sector.
Solid Biosciences Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.23, Solid Biosciences Inc. trades at 2.8x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -67.8%, return on invested capital of -61.3% and a free cash flow yield of -28.8%. On the balance sheet: a debt-to-equity ratio of 0.06 and a current ratio of 11.99. Over the past 52 weeks the share price ranged from $4.24 to $11.45, with a beta of 2.63.
Solid Biosciences Inc. does not currently pay a dividend.
23 Wall Street analyst ratings cover the stock: 18 Buy and 5 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.